Clinical trials
Clinical Trials clinical trials
Below are recruiting clinical trials clinical trials, each written for real people, not researchers. We’re tracking 1,073 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07469085RecruitingPhase 1
Safety study of SV003 in healthy volunteers
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
ShanghaiAges 18–45 - NCT07469683RecruitingPhase 2
Combination therapy for advanced kidney cancer after first-line treatment
This trial tests a combination of two drugs (SLC-3010 and axitinib) versus axitinib alone for people with advanced clear cell kidney cancer that has progressed after initial treatment. It aims to see if the combination is safer and more effective.
SeoulAges 19 years+ - NCT07477990RecruitingPhase 3
Testing a digital device for anxiety treatment
This trial is testing a digital device called Aurora that helps treat moderate to severe anxiety. It compares the device to standard anxiety medications, so you may receive either the device or a pill. The goal is to see if the device can work as well as medication without the side effects.
Mexico City, Mexico CityAges 18–65 - NCT07485075Recruiting
Digital support to cut salt intake for kidney disease
This trial tests a digital program to help people with type 2 diabetes and kidney disease reduce the salt in their diet. The goal is to see if online support can help protect the kidneys and heart.
Herlev, Captial Region of DenmarkAges 18–74 - NCT06989775Recruiting
BoxX-NoAF Trial: Preventing Stroke During Heart Surgery
This trial tests a device to close a small pouch in the heart during planned bypass surgery, to help prevent future strokes. It is for people who have never had an irregular heartbeat and are at higher stroke risk due to age and other factors.
Jonesboro, ArkansasAges 65 years+ - NCT07489716RecruitingPhase 2
Study of SHR-1826 for advanced non-small cell lung cancer
This trial tests a new drug, SHR-1826, for people with advanced or metastatic non-small cell lung cancer that has gotten worse after previous treatment. The goal is to see if the drug can help control the cancer.
Jinan, ShandongAges 18–75 - NCT07493044RecruitingPhase 1
Study of Super CAR-T for advanced liver cancer (GPC3-positive)
This trial tests a new cell therapy called Super CAR-T for people with advanced liver cancer that has GPC3 protein. It aims to see if the treatment is safe and effective. You may be eligible if your cancer has not responded to or stopped working on at least two standard treatments.
Guangzhou, GaungdongAges 18–75 - NCT07495202RecruitingPhase 1
Monkeypox vaccine trial for healthy adults
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
Shenzhen, GuangdongAges 18–59 - NCT07495397Recruiting
Daphnetin plus chemo for advanced ovarian cancer maintenance
This trial is testing a combination of two drugs—daphnetin capsules and a standard chemotherapy (TC regimen)—as a targeted maintenance therapy after initial surgery for advanced ovarian cancer. The goal is to see if this treatment can help keep the cancer from coming back.
Changchun, JilinAges 18–75 - NCT07496372RecruitingPhase 3
Stem cell injection for advanced heart failure
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07497555Recruiting
Pecan nut oil for inflammation in overweight adults
This study tests if taking pecan nut oil every day can reduce inflammation in adults who are overweight. It may help improve health and lower the risk of future disease.
Monterrey, Nuevo LeónAges 18–55 - NCT07514611Recruiting
Weight Loss Guidance for Heart Disease and Obesity
This trial tests whether using a smartphone app to guide weight loss helps people with coronary heart disease (a condition where blood vessels to the heart are narrowed) and obesity lose weight safely. The goal is to see if this personalized digital guidance can improve your health outcomes.
Guangzhou, GuangdongAges 18–65 - NCT07521969Recruiting
Outpatient care after emergency appendix removal surgery
This trial tests whether patients with a specific type of appendix infection (gangrenous appendicitis) can safely recover at home instead of staying in the hospital after surgery. The goal is to see if home-based care with close follow-up visits works as well as traditional hospital stays.
Seville, SevillaAges 14 years+ - NCT07530198RecruitingPhase 1
HIV DNA vaccine test for people on stable treatment
This study tests a new DNA vaccine (ICVAX) designed to help your immune system better control HIV. You'll receive injections over several months if your HIV is well-controlled with current medications.
Shatin, New TerritoriesAges 18–60 - NCT07546240Recruiting
Radiation therapy for persistent heel pain
This trial tests whether targeted radiation can relieve long-lasting heel pain (plantar fasciitis) that hasn't improved with other treatments. If your heel pain has lasted months and other options haven't worked, radiation might help reduce pain and improve walking.
GliwiceAges 40 years+ - NCT07547735RecruitingPhase 2
Stem Cell Treatment for Knee Osteoarthritis
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
WuhanAges 40–70 - NCT07547787Recruiting
Long-term safety follow-up for cadonilimab study participants
This is a follow-up study for people who previously received cadonilimab (AK104), an experimental cancer drug, in an earlier clinical trial. Researchers will check in with you periodically to monitor your health and collect information about how you're doing long-term.
BeijingAges Any age - NCT07548177RecruitingPhase 2
Combination drug study for advanced soft tissue sarcoma
This study tests two cancer drugs (benmelstobart and anlotinib) together to treat alveolar soft part sarcoma, a rare soft tissue cancer that has spread or cannot be surgically removed. The drugs work by boosting the immune system and blocking tumor blood vessel growth.
Beijing, Beijing MunicipalityAges 14 years+ - NCT07552012RecruitingPhase 2
FXS5626 for Non-Infectious Eye Inflammation
This trial tests a new drug called FXS5626 to treat non-infectious uveitis—inflammation inside the eye that doesn't come from infection. The study looks at whether this drug can reduce eye inflammation and improve vision in people whose condition isn't controlled with steroid eye drops and oral steroids alone.
Chongqing, Chongqing MunicipalityAges 18–70 - NCT07552389RecruitingPhase 3
Blood Pressure and Diabetes Combination Drug Trial
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
SeoulAges 19 years+ - NCT07554820RecruitingPhase 4
Heart Protection in Rheumatoid Arthritis With New Medications
This study compares two treatment approaches for people with active rheumatoid arthritis who also have heart disease risk factors. It tests whether a newer drug called tofacitinib, combined with cholesterol medication, can better protect the heart than traditional TNF-inhibitor treatments.
Lahore, Punjab ProvinceAges 50–85 - NCT07558538RecruitingEarly Phase 1
Inhaled Growth Factor Treatment for Severe Lung Failure
This early-stage trial tests whether an inhaled medication called recombinant human keratinocyte growth factor-2 (rh-KGF-2) can help patients with acute respiratory distress syndrome (ARDS)—a serious condition where the lungs cannot deliver enough oxygen to the blood. The drug is designed to help repair lung tissue damage.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07562438RecruitingPhase 2
Lutetium-177 Treatment for Advanced Prostate Cancer
This trial tests a radioactive medication (177Lu-P17-088) designed to target and treat prostate cancer that has spread to other parts of the body and stopped responding to hormone therapy. The medication is guided to cancer cells using a special imaging scan, potentially offering a new treatment option for men who have already tried other standard therapies.
Fuzhou, FujianAges 18–90 - NCT07570758RecruitingPhase 2
Testing ERX1000 to Help Adults Manage Obesity
This study tests whether a new medication called ERX1000 is safe and well-tolerated in adults with obesity. The trial will help doctors understand if this treatment could be helpful for weight management.
Louisville, KentuckyAges 18–60
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical trials?
- Yes. Clin2 currently lists 1,073 recruiting clinical trials studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trials trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trials trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Clinical Competence
- Clinical High Risk for Psychosis (CHR)
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Decision Support
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.